Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Non-Current Liabilities: 2021-2025

Historic Total Non-Current Liabilities for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $18.4 million.

  • Roivant Sciences' Total Non-Current Liabilities fell 58.93% to $257.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $257.0 million, marking a year-over-year decrease of 58.93%. This contributed to the annual value of $18.4 million for FY2025, which is 19.96% up from last year.
  • As of FY2025, Roivant Sciences' Total Non-Current Liabilities stood at $18.4 million, which was down 92.81% from $256.1 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Total Non-Current Liabilities ranged from a high of $765.0 million in FY2023 and a low of $15.4 million during FY2024.
  • In the last 3 years, Roivant Sciences' Total Non-Current Liabilities had a median value of $256.1 million in 2024 and averaged $355.7 million.
  • In the last 5 years, Roivant Sciences' Total Non-Current Liabilities surged by 52.46% in 2023 and then tumbled by 97.99% in 2024.
  • Over the past 5 years, Roivant Sciences' Total Non-Current Liabilities (Yearly) stood at $519.5 million in 2021, then reached $521.4 million in 2021, then fell by 3.42% to $501.8 million in 2022, then spiked by 44.66% to $754.3 million in 2022, then skyrocketed by 52.46% to $765.0 million in 2023, then dropped by 4.07% to $723.7 million in 2023, then slumped by 97.99% to $15.4 million in 2024, then plummeted by 64.62% to $256.1 million in 2024, then rose by 19.96% to $18.4 million in 2025.